Radiopharmaceuticals Market Size And Forecast According to Business Research Reports, the Global Radiopharmaceuticals Market was valued at USD 3.75 Billion in 2018 and is projected to reach USD 5.84 Billion by 2026, growing at a CAGR of 5.66% from 2019 to 2026. The latest survey on Global Radiopharmaceuticals Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunities available and trend in Radiopharmaceuticals Market. The report aims to present the analysis of Global Radiopharmaceuticals Market By Product Type, By Application, By Region – North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities What are Radiopharmaceuticals?
Radiopharmaceuticals are a group of radioactive pharmaceuticals drug. It can be used in diagnostic and therapeutic procedures. Radiopharmaceuticals are medicinal formulations containing radioisotopes, which are used in major clinical areas for diagnosis or therapy. The facilities for production, use, and storage of radiopharmaceuticals are subjected to licensing by regional and national authorities. There are around 50 US FDA approved radiopharmaceuticals present for diagnostic and therapeutic applications in the market. It has applications in areas such as neurology, oncology, cardiology, and many others. In addition, certain radiopharmaceuticals have applications such as certain iodine isotopes.
Radiopharmaceuticals Market OverviewGlobal Radiopharmaceuticals Market Outlook In the report, the market outlook section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
The rising incidence and prevalence of cancer and cardiovascular diseases that rising the need for early diagnosis and treatment will propel the global radiopharmaceuticals market growth. According to the World Health Organization, 9.6 million deaths are estimated in 2018. Furthermore, globally 17.9 million deaths occur due to cardiovascular diseases each year. Moreover, major market developments by key players booming market growth. For instance, in January 2018, Advanced Accelerator Application received US FDA approval for Lutathera used in the treatment of gastroenteropancreatic neuroendocrine tumors. Also rising healthcare expenditure, growing awareness about the benefits of radiopharmaceuticals and rising preference of SPECT and PET scans is expected to drive the market growth. However, the high cost of development of radiopharmaceuticals, supply shortage of radiopharmaceuticals and short half-life of radiopharmaceuticals is expected to impede the growth of the radiopharmaceuticals market. Business Research Reports narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The “Global Radiopharmaceuticals Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market. Global Radiopharmaceuticals Market Competitive Landscape
The “Global Radiopharmaceuticals Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Bayer AG, Cardinal Health, Advanced Accelerator Applications, Mallinckrodt., Lantheus Medical Imaging, Inc., General Electric Company, Surgery Theater, Bracco Imaging S.p.A., Nordion Inc., Positron Corporation. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally. Global Radiopharmaceuticals Market, By Product Type
Top Trending Reports Global Stretch Marks Treatment Market Size By Treatment, By Geographic Scope And Forecast Global Primary Biliary Cirrhosis Drug Market Size And Forecast Research Methodology of Business Research Reports: Research Methodology Of Business Research Reports To know more about the Research Methodology and other aspects of the research study, kindly Get in touch with our sales team. Reasons to Purchase this Report
1 INTRODUCTION OF GLOBAL RADIOPHARMACEUTICALS MARKET 1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF BUSINESS RESEARCH REPORTS 3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources
4 GLOBAL RADIOPHARMACEUTICALS MARKET OUTLOOK 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis
5 GLOBAL RADIOPHARMACEUTICALS MARKET, BY PRODUCT TYPE 5.1 Overview 5.2 Diagnostic 5.2.1 SPECT 5.2.2 PET isotopes 5.3 Therapeutic 5.3.1 Classified alpha emitters 5.3.2 Beta emitters 5.3.3 Brachytherapy
6 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION 6.1 Overview 6.2 Cardiology 6.3 Neurology 6.4 Oncology 6.5 Endocrinology 6.6 Others
7 GLOBAL RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY 7.1 Overview 7.2 North America 7.2.1 U.S. 7.2.2 Canada 7.2.3 Mexico 7.3 Europe 7.3.1 Germany 7.3.2 U.K. 7.3.3 France 7.3.4 Rest of Europe 7.4 Asia Pacific 7.4.1 China 7.4.2 Japan 7.4.3 India 7.4.4 Rest of Asia Pacific 7.5 Rest of the World 7.5.1 Latin America 7.5.2 Middle East
8 GLOBAL RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE 8.1 Overview 8.2 Company Market Ranking 8.3 Key Development Strategies
9 COMPANY PROFILES
9.1 Bayer AG 9.1.1 Overview 9.1.2 Financial Performance 9.1.3 Product Outlook 9.1.4 Key Developments
9.2 Cardinal Health 9.2.1 Overview 9.2.2 Financial Performance 9.2.3 Product Outlook 9.2.4 Key Developments
9.3 Advanced Accelerator Applications 9.3.1 Overview 9.3.2 Financial Performance 9.3.3 Product Outlook 9.3.4 Key Developments
9.4 Mallinckrodt. 9.4.1 Overview 9.4.2 Financial Performance 9.4.3 Product Outlook 9.4.4 Key Developments
9.5 Lantheus Medical Imaging, Inc. 9.5.1 Overview 9.5.2 Financial Performance 9.5.3 Product Outlook 9.5.4 Key Developments
9.6 General Electric Company 9.6.1 Overview 9.6.2 Financial Performance 9.6.3 Product Outlook 9.6.4 Key Developments
9.7 Surgery Theater 9.7.1 Overview 9.7.2 Financial Performance 9.7.3 Product Outlook 9.7.4 Key Developments
9.8 Bracco Imaging S.p.A. 9.8.1 Overview 9.8.2 Financial Performance 9.8.3 Product Outlook 9.8.4 Key Developments
9.9 Nordion Inc. 9.9.1 Overview 9.9.2 Financial Performance 9.9.3 Product Outlook 9.9.4 Key Developments
9.10 Positron Corporation 9.10.1 Overview 9.10.2 Financial Performance 9.10.3 Product Outlook 9.10.4 Key Developments
10 Appendix 10.1 Related Research
USA : +1 7162260907
UK : +44 email@example.com
According to Business Research Reports, Global In-Store Analytics Market was valued at USD 941 Million in 2018 and is projected to reach USD 4,252.1 Million by 2026, growing at a CAGR of 20.64% from 2019 to 2026.
February 2020 | Price: $3950
According to Business Research Reports, Global Intelligent PDU Market was valued at USD 1.32 Billion in 2018 and is projected to reach USD 2.48 Billion by 2026, growing at a CAGR of 8.12% from 2019 to 2026.
February 2020 | Price: $3950
According to Business Research Reports, Middle East & Africa Cybersecurity Market was valued at USD 5.92 Billion in 2018 and is projected to reach USD 17.30 Billion by 2026, growing at a CAGR of 14.35% from 2019 to 2026.
February 2020 | Price: $3950